ArticleCureus2026
Impact of the COVID-19 Pandemic on Peripartum Fever: A Comparative Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOVID-19 has been associated with febrile conditions during the peripartum period. Although understanding of COVID-19 has improved, the real impact of this disease among pyretic women in the peripartum period is poorly described. Our aim was to assess the etiology and consequences of maternal and neonatal fever since the pandemic.
methodsThis comparative retrospective study is based on a comparison of all pyretic pregnant women admitted for delivery at >15 weeks' gestation at the Centre Hospitalier Universitaire (CHU) Charleroi in Charleroi, Belgium, during the COVID-19 pandemic (February 21, 2020, to December 14, 2020) and outside the pandemic (February 21, 2019, to December 14, 2019).
resultsA total of 80 patients were included in both cohorts, 49 including four COVID-19-infected patients during the pandemic period and 31 in the control group. The main fever etiologies were intra-amniotic infection (p=0.12) and urinary tract infection (p=0.75). Pandemic newborns had better outcomes regarding neonatal intensive care unit (NICU) admission (p=0.004), fever (p=0.02), Apgar score 7 at one minute (p=0.039), and time of hospitalization (p=0.045).
conclusionThe COVID-19 pandemic had no impact on peripartum fever etiology and maternal adverse events, but there is a potential association between improved pyretic outcomes during the COVID-19 pandemic. This positive effect might be explained by the behavioral and socio-environmental modifiers influencing health and well-being during the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.